Laboratory for Drug Discovery in Neurodegeneration, Harvard NeuroDiscovery Center, Brigham & Women's Hospital and Harvard Medical School, 65 Landsdowne Street, Cambridge, Massachusetts 02139, United States.
J Org Chem. 2011 Oct 21;76(20):8477-82. doi: 10.1021/jo201237h. Epub 2011 Sep 13.
Nitrogen-containing fused heterocycles comprise many compounds that demonstrate interesting biological activities. A new synthetic approach involving Mitsunobu alkylation of imidazoles, pyrroles, and indoles followed by palladium-catalyzed cyclization has been developed providing access to fused heterocycles with a defined stereochemistry α to nitrogen. While ethyl imidazole or indole carboxylates are good substrates for Mitsunobu alkylation with optically pure secondary benzylic alcohols, the corresponding pyrroles are poor substrates presumably due to the increased pK(a) of the NH. The presence of a synthetically versatile trichloroacetyl functional group on the pyrroles significantly reduces the pK(a) and thereby facilitates Mitsunobu alkylation. Subsequent cyclization of the alkylated products mediated by palladium in the presence or absence of a ligand gave fused heterocycles in good to excellent yields.
含氮稠合杂环包含许多具有有趣生物活性的化合物。一种新的合成方法,包括咪唑、吡咯和吲哚的 Mitsunobu 烷基化,以及随后的钯催化环化,已经被开发出来,提供了具有确定立体化学的稠合杂环α到氮。虽然乙基咪唑或吲哚羧酸酯是与光学纯仲苄醇进行 Mitsunobu 烷基化的良好底物,但相应的吡咯则是较差的底物,可能是由于 NH 的 pK(a)增加。在吡咯上存在一个合成多功能的三氯乙酰基官能团,显著降低了 pK(a),从而促进了 Mitsunobu 烷基化。随后,在钯存在或不存在配体的情况下,对烷基化产物进行环化,得到了具有良好至优异收率的稠合杂环。